Your browser doesn't support javascript.
loading
Heat Inactivation of Nipah Virus for Downstream Single-Cell RNA Sequencing Does Not Interfere with Sample Quality.
Hume, Adam J; Olejnik, Judith; White, Mitchell R; Huang, Jessie; Turcinovic, Jacquelyn; Heiden, Baylee; Bawa, Pushpinder S; Williams, Christopher J; Gorham, Nickolas G; Alekseyev, Yuriy O; Connor, John H; Kotton, Darrell N; Mühlberger, Elke.
Afiliação
  • Hume AJ; Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Olejnik J; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02218, USA.
  • White MR; Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Huang J; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02218, USA.
  • Turcinovic J; Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Heiden B; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02218, USA.
  • Bawa PS; Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA.
  • Williams CJ; The Pulmonary Center and Department of Medicine, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Gorham NG; Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Alekseyev YO; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02218, USA.
  • Connor JH; Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Kotton DN; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02218, USA.
  • Mühlberger E; Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA.
Pathogens ; 13(1)2024 Jan 09.
Article em En | MEDLINE | ID: mdl-38251369
ABSTRACT
Single-cell RNA sequencing (scRNA-seq) technologies are instrumental to improving our understanding of virus-host interactions in cell culture infection studies and complex biological systems because they allow separating the transcriptional signatures of infected versus non-infected bystander cells. A drawback of using biosafety level (BSL) 4 pathogens is that protocols are typically developed without consideration of virus inactivation during the procedure. To ensure complete inactivation of virus-containing samples for downstream analyses, an adaptation of the workflow is needed. Focusing on a commercially available microfluidic partitioning scRNA-seq platform to prepare samples for scRNA-seq, we tested various chemical and physical components of the platform for their ability to inactivate Nipah virus (NiV), a BSL-4 pathogen that belongs to the group of nonsegmented negative-sense RNA viruses. The only step of the standard protocol that led to NiV inactivation was a 5 min incubation at 85 °C. To comply with the more stringent biosafety requirements for BSL-4-derived samples, we included an additional heat step after cDNA synthesis. This step alone was sufficient to inactivate NiV-containing samples, adding to the necessary inactivation redundancy. Importantly, the additional heat step did not affect sample quality or downstream scRNA-seq results.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article